Simba Gill
Director/Board Member at FOGHORN THERAPEUTICS INC.
Net worth: 199 481 $ as of 29/04/2024
Simba Gill active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Director/Board Member | 30/06/2017 | - |
| Independent Dir/Board Member | 30/06/2017 | - |
Career history of Simba Gill
Former positions of Simba Gill
| Companies | Position | Start | End |
|---|---|---|---|
| EVELO BIOSCIENCES, INC. | Director/Board Member | 31/05/2015 | 19/11/2023 |
| Chief Executive Officer | 31/05/2015 | 19/11/2023 | |
| Director of Finance/CFO | 02/06/2022 | 31/08/2022 | |
| President | 31/05/2015 | 19/11/2023 | |
| Treasurer | 31/01/2020 | 31/05/2021 | |
| REALM THERAPEUTICS PLC | Director/Board Member | 31/12/2015 | 31/12/2018 |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Director/Board Member | 31/12/2005 | 31/12/2014 |
| Chief Executive Officer | 31/12/2005 | 31/12/2014 | |
| Founder | 31/12/2005 | 31/12/2014 | |
| President | 31/12/2005 | 31/12/2014 | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Director of Finance/CFO | 31/12/1996 | 26/11/2013 |
| President | 31/12/1996 | 26/11/2013 | |
TPG Growth LLC
 TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Private Equity Investor | - | 29/11/2007 |
Blackfynn, Inc.
 Blackfynn, Inc. Internet Software/ServicesTechnology Services Blackfynn, Inc. provides treatments for neurological disease. Its new tools and technologies are generating. The company was founded by Amanda Christini and Joost Wagenaar and is headquartered in Philadelphia, PA. | Chairman | - | - |
| CODEXIS, INC. | Director/Board Member | - | - |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | - | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
Training of Simba Gill
| INSEAD | Masters Business Admin |
| King's College London | Doctorate Degree |
Statistics
International
| United States | 8 |
| United Kingdom | 4 |
| Germany | 2 |
Operational
| Director/Board Member | 5 |
| President | 3 |
| Director of Finance/CFO | 2 |
Sectoral
| Health Technology | 5 |
| Commercial Services | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CODEXIS, INC. | Process Industries |
| EVELO BIOSCIENCES, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Private companies | 7 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Finance |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Blackfynn, Inc.
Blackfynn, Inc. Internet Software/ServicesTechnology Services Blackfynn, Inc. provides treatments for neurological disease. Its new tools and technologies are generating. The company was founded by Amanda Christini and Joost Wagenaar and is headquartered in Philadelphia, PA. | Technology Services |
- Stock Market
- Insiders
- Simba Gill
- Experience